Anthem Biosciences tells Delhi High Court it won't launch products using anti-cancer drug Alectinib
The undertaking was made in a patent infringement suit by Japanese drug manufacturing company Chugai Pharmaceutical to restrain Anthem from using Alectinib in its drugs.
Delhi HC and Anthem Biosciences Limited logo and Chugai Seiyaku Kabushiki Kaisha
Anthem Biosciences Limited has given an undertaking before the Delhi High Court saying that it will not launch any product using anti-cancer drug Alectinib [Chugai Seiyaku Kabushiki Kaisha & Anr v. Anthem Biosciences Limited].
